247 related articles for article (PubMed ID: 28586006)
41. NF-κB signaling mechanisms in HTLV-1-induced adult T-cell leukemia/lymphoma.
Harhaj EW; Giam CZ
FEBS J; 2018 Sep; 285(18):3324-3336. PubMed ID: 29722927
[TBL] [Abstract][Full Text] [Related]
42. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.
Shishodia S; Amin HM; Lai R; Aggarwal BB
Biochem Pharmacol; 2005 Sep; 70(5):700-13. PubMed ID: 16023083
[TBL] [Abstract][Full Text] [Related]
43. The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells.
Ishikawa C; Mori N
Eur J Pharmacol; 2021 Oct; 908():174373. PubMed ID: 34303663
[TBL] [Abstract][Full Text] [Related]
44. Butein suppresses ICAM-1 expression through the inhibition of IκBα and c-Jun phosphorylation in TNF-α- and PMA-treated HUVECs.
Kojima R; Kawachi M; Ito M
Int Immunopharmacol; 2015 Feb; 24(2):267-275. PubMed ID: 25533502
[TBL] [Abstract][Full Text] [Related]
45. WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.
Moles R; Bai XT; Chaib-Mezrag H; Nicot C
J Hematol Oncol; 2016 Nov; 9(1):121. PubMed ID: 27829440
[TBL] [Abstract][Full Text] [Related]
46. Bcl-3 suppresses Tax-induced NF-κB activation through p65 nuclear translocation blockage in HTLV-1-infected cells.
Wang J; Li J; Huang Y; Song X; Niu Z; Gao Z; Wang H
Int J Oncol; 2013 Jan; 42(1):269-76. PubMed ID: 23135533
[TBL] [Abstract][Full Text] [Related]
47. CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.
Ishikawa C; Kawakami H; Uchihara JN; Senba M; Mori N
Biochim Biophys Acta; 2013 Jun; 1833(6):1542-52. PubMed ID: 23507197
[TBL] [Abstract][Full Text] [Related]
48. Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway.
Bai X; Ma Y; Zhang G
Oncol Rep; 2015 Jun; 33(6):3085-92. PubMed ID: 25962638
[TBL] [Abstract][Full Text] [Related]
49. Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir.
Dewan MZ; Uchihara JN; Terashima K; Honda M; Sata T; Ito M; Fujii N; Uozumi K; Tsukasaki K; Tomonaga M; Kubuki Y; Okayama A; Toi M; Mori N; Yamamoto N
Blood; 2006 Jan; 107(2):716-24. PubMed ID: 16174765
[TBL] [Abstract][Full Text] [Related]
50. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
51. p53 dysfunction precedes the activation of nuclear factor-κB during disease progression in mice expressing Tax, a human T-cell leukemia virus type 1 oncoprotein.
Ohsugi T; Ishida T; Shimasaki T; Okada S; Umezawa K
Carcinogenesis; 2013 Sep; 34(9):2129-36. PubMed ID: 23633516
[TBL] [Abstract][Full Text] [Related]
52. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
53. Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells.
Bai XT; Moles R; Chaib-Mezrag H; Nicot C
J Hematol Oncol; 2015 Oct; 8():117. PubMed ID: 26497583
[TBL] [Abstract][Full Text] [Related]
54. Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.
Baydoun HH; Cherian MA; Green P; Ratner L
Retrovirology; 2015 Aug; 12():71. PubMed ID: 26265053
[TBL] [Abstract][Full Text] [Related]
55. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
56. Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.
Ichikawa T; Nakahata S; Fujii M; Iha H; Morishita K
Sci Rep; 2015 Aug; 5():12841. PubMed ID: 26269411
[TBL] [Abstract][Full Text] [Related]
57. Dimethyl Fumarate Induces Apoptosis
Maeta T; Sato T; Asano K; Ito S
Anticancer Res; 2022 May; 42(5):2301-2309. PubMed ID: 35489748
[TBL] [Abstract][Full Text] [Related]
58. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.
Matsuda T; Almasan A; Tomita M; Uchihara JN; Masuda M; Ohshiro K; Takasu N; Yagita H; Ohta T; Mori N
J Virol; 2005 Feb; 79(3):1367-78. PubMed ID: 15650163
[TBL] [Abstract][Full Text] [Related]
59. C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
Guimaraes-Correa AB; Crawford LB; Figueiredo CR; Gimenes KP; Pinto LA; Grassi MFR; Feuer G; Travassos LR; Caires ACF; Rodrigues EG; Marriott SJ
Viruses; 2011 Jul; 3(7):1041-1058. PubMed ID: 21994769
[TBL] [Abstract][Full Text] [Related]
60. Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia-lymphoma cells.
Taniguchi H; Hasegawa H; Sasaki D; Ando K; Sawayama Y; Imanishi D; Taguchi J; Imaizumi Y; Hata T; Tsukasaki K; Uno N; Morinaga Y; Yanagihara K; Miyazaki Y
Cancer Sci; 2014 Dec; 105(12):1601-8. PubMed ID: 25263741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
